ArticleJournal of clinical medicine2023

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.

Xavier Roblin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.